Company Filing History:
Years Active: 2000-2001
Title: Zora D Modrusan: Innovator in Molecular Detection
Introduction
Zora D Modrusan is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of molecular detection, particularly in the detection of antibiotic-resistant bacteria. His innovative approaches have led to the development of methods that enhance the accuracy and efficiency of detecting vancomycin-resistant enterococci.
Latest Patents
Zora D Modrusan holds 2 patents that focus on advanced methodologies for detecting antibiotic resistance. His latest patents include:
1. **Compositions and methods for detecting vancomycin resistant enterococci by cycling probe reactions** - This patent outlines a method for determining the presence of the vancomycin antibiotic-resistant gene in biological samples. The process involves treating cells to expose single-stranded target nucleic acids, hybridizing them with complementary probes, and detecting cleaved portions of the nucleic acid probe to confirm the presence of the resistant gene.
2. **Additives for use in cycling probe reactions** - This patent describes a method for detecting target nucleic acid molecules through a series of reactions involving a target nucleic acid, a single-stranded nucleic acid probe, and an enzyme capable of cleaving the probe. The method allows for the cycling of the target to a new probe, facilitating the detection of the target nucleic acid.
Career Highlights
Zora D Modrusan is currently associated with Id Biomedical Corporation, where he continues to innovate in the field of molecular diagnostics. His work has been instrumental in advancing techniques that are crucial for public health, particularly in combating antibiotic resistance.
Collaborations
Zora has collaborated with notable colleagues, including Faouzi Bekkaoui and Isabelle A Piche, who contribute to the research and development efforts at Id Biomedical Corporation.
Conclusion
Zora D Modrusan's contributions to molecular detection and antibiotic resistance highlight his role as a leading inventor in the field. His innovative patents and ongoing work at Id Biomedical Corporation continue to impact public health positively.